Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets
The Food and Drug Administration Adverse Event Reporting System (FAERS) remains the primary source for post-marketing pharmacovigilance. The system is largely un-curated, unstandardized, and lacks a method for linking drugs to the chemical structures of their active ingredients, increasing noise and...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-08-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/25818 |